Longevity & AgingCan Vascular Biomarkers Sharpen Hypertension Care and Cut Heart Risk?
Vascular biomarkers, measures that reflect atherosclerosis and arterial health, are linked to cardiovascular events and already appear in several hypertension guidelines for risk stratification and prognosis. This expert review examines the evidence for various biomarkers in hypertension practice, how guidelines interpret them, and where the field may go next. The author notes a key gap: some guidelines give cutoff values for physiological vascular tests, but reference values for blood-based biomarkers are not clearly defined. The review calls for large studies to set appropriate blood biomarker cutoffs and for more evidence on whether measuring these markers actually improves outcomes. It also highlights the cardio-ankle vascular index (CAVI) as an area awaiting further data. Based on the abstract alone, the central message is that these tools predict risk, but proof that they improve patient outcomes is still being built.